Literature DB >> 9519410

The allosteric regulation of pyruvate kinase by fructose-1,6-bisphosphate.

M S Jurica1, A Mesecar, P J Heath, W Shi, T Nowak, B L Stoddard.   

Abstract

BACKGROUND: Yeast pyruvate kinase (PK) catalyzes the final step in glycolysis. The enzyme therefore represents an important control point and is allosterically activated by fructose-1,6-bisphosphate (FBP). In mammals the enzyme is found as four different isozymes with different regulatory properties: two of these isozymes are produced by alternate splicing. The allosteric regulation of PK is directly related to proliferation of certain cell types, as demonstrated by the expression of an allosterically regulated isozyme in tumor cells. A model for the allosteric transition from the inactive (T) state to the active (R) state has been proposed previously, but until now the FBP-binding site had not been identified.
RESULTS: We report here the structures of PK from yeast complexed with a substrate analog and catalytic metal ions in the presence and absence of bound FBP. The allosteric site is located 40 A from the active site and is entirely located in the enzyme regulatory (C) domain. A phosphate-binding site for the allosteric activator is created by residues encoded by a region of the gene corresponding to the alternately spliced exon of mammalian isozymes. FBP activation appears to induce several conformational changes among active-site sidechains through a mechanism that is most likely to involve significant domain motions, as previously hypothesized.
CONCLUSIONS: The structure and location of the allosteric activator site agrees with the pattern of alternate genetic splicing of the PK gene in multicellular eukaryotes that distinguishes between a non-regulated isozyme and the regulated fetal isozymes. The conformational differences observed between the active sites of inactive and fully active PK enzymes is in agreement with the recently determined thermodynamic mechanism of allosteric activation through a 'metal relay' that increases the affinity of the enzyme for its natural phosphoenolpyruvate substrate.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9519410     DOI: 10.1016/s0969-2126(98)00021-5

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  140 in total

1.  X-ray structure of HPr kinase: a bacterial protein kinase with a P-loop nucleotide-binding domain.

Authors:  S Fieulaine; S Morera; S Poncet; V Monedero; V Gueguen-Chaignon; A Galinier; J Janin; J Deutscher; S Nessler
Journal:  EMBO J       Date:  2001-08-01       Impact factor: 11.598

2.  Conformational Dynamics and Allostery in Pyruvate Kinase.

Authors:  Katherine A Donovan; Shaolong Zhu; Peter Liuni; Fen Peng; Sarah A Kessans; Derek J Wilson; Renwick C J Dobson
Journal:  J Biol Chem       Date:  2016-02-15       Impact factor: 5.157

Review 3.  Pyruvate kinase: Function, regulation and role in cancer.

Authors:  William J Israelsen; Matthew G Vander Heiden
Journal:  Semin Cell Dev Biol       Date:  2015-08-13       Impact factor: 7.727

4.  PKM2-dependent metabolic reprogramming in CD4+ T cells is crucial for hyperhomocysteinemia-accelerated atherosclerosis.

Authors:  Silin Lü; Jiacheng Deng; Huiying Liu; Bo Liu; Juan Yang; Yutong Miao; Jing Li; Nan Wang; Changtao Jiang; Qingbo Xu; Xian Wang; Juan Feng
Journal:  J Mol Med (Berl)       Date:  2018-05-07       Impact factor: 4.599

5.  Butyrate Suppresses the Proliferation of Colorectal Cancer Cells via Targeting Pyruvate Kinase M2 and Metabolic Reprogramming.

Authors:  Qingran Li; Lijuan Cao; Yang Tian; Pei Zhang; Chujie Ding; Wenjie Lu; Chenxi Jia; Chang Shao; Wenyue Liu; Dong Wang; Hui Ye; Haiping Hao
Journal:  Mol Cell Proteomics       Date:  2018-05-08       Impact factor: 5.911

6.  PK-M2-mediated metabolic changes in breast cancer cells induced by ionizing radiation.

Authors:  Le Zhang; Justine Bailleul; Taha Yazal; Kevin Dong; David Sung; Amy Dao; Laura Gosa; David Nathanson; Kruttika Bhat; Sara Duhachek-Muggy; Claudia Alli; Milana Bochkur Dratver; Frank Pajonk; Erina Vlashi
Journal:  Breast Cancer Res Treat       Date:  2019-08-01       Impact factor: 4.872

Review 7.  Enzymatic and nonenzymatic protein acetylations control glycolysis process in liver diseases.

Authors:  Juan Li; Tongxin Wang; Jun Xia; Weilei Yao; Feiruo Huang
Journal:  FASEB J       Date:  2019-08-01       Impact factor: 5.191

8.  Identification of small molecule inhibitors of pyruvate kinase M2.

Authors:  Matthew G Vander Heiden; Heather R Christofk; Eli Schuman; Alexander O Subtelny; Hadar Sharfi; Edward E Harlow; Jun Xian; Lewis C Cantley
Journal:  Biochem Pharmacol       Date:  2009-12-11       Impact factor: 5.858

9.  Addressing the diagnostic gaps in pyruvate kinase deficiency: Consensus recommendations on the diagnosis of pyruvate kinase deficiency.

Authors:  Paola Bianchi; Elisa Fermo; Bertil Glader; Hitoshi Kanno; Archana Agarwal; Wilma Barcellini; Stefan Eber; James D Hoyer; David J Kuter; Tabita Magalhães Maia; Maria Del Mar Mañu-Pereira; Theodosia A Kalfa; Serge Pissard; José-Carlos Segovia; Eduard van Beers; Patrick G Gallagher; David C Rees; Richard van Wijk
Journal:  Am J Hematol       Date:  2018-11-28       Impact factor: 10.047

10.  Regulation of yeast pyruvate kinase by ultrasensitive allostery independent of phosphorylation.

Authors:  Yi-Fan Xu; Xin Zhao; David S Glass; Farnaz Absalan; David H Perlman; James R Broach; Joshua D Rabinowitz
Journal:  Mol Cell       Date:  2012-08-16       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.